Everything we do is held to the highest standards in accordance with our ISO 9001:2015 compliant quality management system.
Fully supporting your medical device products without overburdening your commercial teams can be challenging, especially with pressures to hit your increasing sales quota while minimizing SG&A costs.
With Novasyte's Contract Clinical Program, we help our medtech clients respond to market challenges with focused in-servicing and peer-to-peer product training pre- and post-sale. After building, deploying and managing our teams, we measure and track the progress and associated spend.
Key Benefits:
- Increase flexibility to scale up and down as needed
- Maximize your team's bandwidth while we serve as an extension of your team
- Increase product adoption and help improve patient outcomes
- Drive faster revenue recognition by expediting the in-servicing timeline
- Customize the strategic implementation plan to meet your program goals
- ISO 9001:2015 Quality Management System driving best-in-class processes and repeatable outcomes
- Receive real-time, data analytics to maximize program success
- Gain access to our network of 2,200 quality consultants across the U.S. and Canada
Powered by People and Technology
Novasyte builds, deploys and manages all field teams with quality management standards that are ISO 9001:2015 certified - allowing us to deliver consistent results and continually improve satisfaction for you and your customers.
After expediting the scheduling process on our Novasyte NOW platform, we measure and track the progress and associated spend in our proprietary Novasyte LYNC platform. This provides real-time visibility into every activity tracked and every dollar spent on Novasyte services so you can stay informed and evaluate where and when support is needed.
Our interactive and customizable dashboards report:
- KPI measurement (e.g. expense-to-service ratios)
- Regional and facility-based activities performed by consultants
- Detailed spend analysis by account, region, product and supervisor
- Spend-to-budget and ROI tracking on Novasyte’s clinical services
Conversion Excellence Industry Report
Our team recently released our Conversion Excellence white paper, outlining industry trends and survey findings on what the top medtech players include in their medical device conversion strategy.
The survey, conducted in Q4 of 2017, reflects the opinions of 40 business leaders who manage conversions for both hardware and disposable products in 14 of the largest, global medical device and diagnostic organizations. The participants, all Novasyte client partners, represent a cross-section of 32 business units. Click here to read the findings.
